While the expression of SIL1 demonstrates low cancer specificity, a recent study found that SIL1 was expressed at higher levels in ~66% of glioblastoma multiforme and lower-grade gliomas compared to normal tissue, and it was particularly high in grade IV gliomas compared to grades I-III [108]. The gene discussed is SIL1; the disease is cancer.